Related Experiment Videos

[Progress in the treatment targeting intracellular signaling in the context of osteoimmunology]

Yoshiya Tanaka1

  • 1School of Medicine, University of Occupational and Environmental Health, Japan.

Clinical Calcium
|October 30, 2012
PubMed

Insights

Targeting Janus kinase (Jak) and Spleen tyrosine kinase (Syk) with inhibitors shows promise for treating autoimmune inflammatory diseases like rheumatoid arthritis and regulating bone destruction. Calcineurin inhibitors also aid immune and bone health.

Area of Science:

  • Molecular Biology
  • Immunology
  • Rheumatology

Context:

  • Cellular signaling pathways are initiated by cell surface receptor-ligand interactions, involving cytokines and antigens.
  • Tyrosine kinases, including Janus kinase (Jak) and Spleen tyrosine kinase (Syk) families, are crucial for transducing these extracellular signals intracellularly.
  • These kinases play significant roles in the pathogenesis of autoimmune inflammatory diseases.

Purpose:

  • To explore the therapeutic potential of targeting intracellular signaling pathways in osteo-immune diseases.
  • To investigate the efficacy of kinase inhibitors and calcineurin inhibitors in immune regulation and bone metabolism.

Summary:

  • Low molecular weight inhibitors targeting Jak and Syk have demonstrated success in treating rheumatoid arthritis and preventing joint destruction.
  • Calcineurin inhibitors, such as tacrolimus and vitamin D, effectively regulate immune responses and bone metabolism by inhibiting nuclear factors.
  • The combined regulation of cellular signals governing immunity and bone metabolism presents a promising therapeutic strategy for osteo-immune diseases.

Impact:

  • Provides a rationale for developing novel treatments for autoimmune and bone-related disorders.
  • Highlights the interconnectedness of immune and bone pathways in disease pathogenesis.
  • Suggests a unified approach to treating complex osteo-immune conditions by modulating key signaling molecules.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...